NHS England | April 2020 | NHS strikes deal on first in a new generation of cancer busting drugs
The NHS has struck a deal which will see hundreds of people a year benefit from a ‘game-changing’ new cancer treatment.
Larotrectinib, will initially be used for children, young people and some adults, and targets tumours according to their genetic make-up, rather than where they originated from in the body.
The revolutionary treatment is the first in a new generation of ‘tumour agnostic’ drugs to be made available on the NHS following the deal endorsed by NICE, the organisation that ensures clinical and cost effectiveness.
Larotrectinib, also known as Vitrakvi, can be used against a wide range of cancers and could offer hope to patients with rare forms of the disease that may previously have been untreatable.
Productivity of the English National Health Service: 2017/18 update | The Centre for Health Economics
This report updates the Centre for Health Economics’ time-series of NHS productivity growth for the period 2016/17 to 2017/18. Overall NHS productivity has increased by 17.99% since 2004/15, with year-on-year growth averaging 1.29%. Since 2009/10, NHS productivity growth has also been positive and has improved substantially faster than the overall economy, measured in terms of gross value added per hour worked.
This eighth report on the financial sustainability of the NHS summarises the financial and operational performance of the NHS as a whole in England in 2018-19; examines the financial performance of local NHS organisations; and examines NHS service transformation and sustainability.
The report finds that the NHS is treating more patients but has not yet achieved the fundamental transformation in services and finance regime needed to meet rising demand. It argues that the short‑term fixes that DHSC, NHS England and NHS Improvement put in place to manage resources in a constrained financial environment are not sustainable. The extra money brought in to stabilise the finances of NHS bodies has continued to drive volatility and variability among trusts, while patient waiting times continue to deteriorate and the number of people waiting for treatment continues to increase.
To bring about lasting stability, the report states that the NHS needs a financial restructuring programme not just a recovery programme. If integrated care systems are to be successful it claims, funding mechanisms and incentives need to support collaborative behaviours.
The King’s Fund | January 2020| The economic influence of the NHS at the local level
A new long read from the King’s Fund has been written to help people working in the NHS understand the level of economic influence their organisations can have and the benefits this can bring to local populations, in a way they may not have considered before (Source: The King’s Fund).
Financial performance report: first quarter 2019/20 | NHS England and NHS Improvement
This report provides an update on the financial performance of NHS England and includes the year to date and forecast position for CCGs, areas of direct commissioning, central running costs and programme budgets. It also includes year to date and forecast performance against commissioner efficiency plans.
There and back – what people tell us about their experiences of travelling to and from NHS services | Healthwatch England
Healthwatch England has carried out a nationwide conversation on the NHS Long Term Plan, engaging with over 30,000 people across the country. They found that travel was a key issue, with nine out of 10 people saying that convenient ways of getting to and from health services is important to them. Indeed, people put transport above other things, such as choice over where to be treated and improving digital access to services.
This briefing brings collates information about people’s experiences of getting to and from appointments at hospitals, GP surgeries and other NHS services. It looks at the different methods of transport, as well as sharing some examples of promising practice. It is intended to help leaders in the NHS understand the barriers people face and explore possible solutions.
Review recommends that councils and the NHS work more closely to co-commission public health services, including health visiting and school nursing | Department of Health and Social Care
The review, conducted by the Department of Health and Social Care, recommends that the NHS work much more closely with local authorities on public health so that commissioning is more joined-up and prevention is embedded into a wider range of health services.
As part of the NHS Long Term Plan, the government committed to reviewing commissioning arrangements for some local authority-commissioned public health services.
Health and Social Care Secretary Matt Hancock confirmed that the departmental review found that local authorities take an active and efficient approach to commissioning services. He also praised local councils for their work in commissioning public health services and confirmed they will continue to lead on this important work.
He acknowledged that many local authorities have taken steps to improve and modernise the services they commission, including through digital delivery, such as online STI testing.
Nuffield Trust | May 2019 | Health & social care explained
An interactive timeline developed by the Nuffield Trust brings 70 years of reform and change in the National Health Service to life, charting the evolution of this public institution from its inception in the post-war years through to the present day.
Centre for Health and the Public Interest | March 2019 | Who decides the price and availability of NHS medicines?
Who decides the price and availability of NHS medicines? is a briefing from the Centre for Health and the Public Interest. The release summarises the key forces determining the price and availability of new medicines in the NHS. It explains the tension between pharmaceutical companies, purchasers (e.g. the NHS), and patients’ representative groups.